Stay updated on Comparing Antiviral Drugs in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.

Latest updates to the Comparing Antiviral Drugs in COVID-19 Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check25 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.0, while the previous version, v2.15.2, has been removed. Additionally, references to specific FDA-regulated drug and device products have been deleted.SummaryDifference1%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference0.3%
Stay in the know with updates to Comparing Antiviral Drugs in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.